Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 74 | 2023 | 2064 | 9.170 |
Why?
|
Neoplasms | 92 | 2024 | 22072 | 4.070 |
Why?
|
Smoking | 48 | 2023 | 9073 | 3.880 |
Why?
|
Resilience, Psychological | 12 | 2022 | 768 | 3.410 |
Why?
|
Mind-Body Therapies | 13 | 2023 | 265 | 3.180 |
Why?
|
Survivors | 36 | 2024 | 2375 | 2.920 |
Why?
|
Lung Neoplasms | 50 | 2024 | 13262 | 2.800 |
Why?
|
Stress, Psychological | 28 | 2022 | 4446 | 2.610 |
Why?
|
Health Behavior | 24 | 2023 | 2622 | 2.460 |
Why?
|
Insurance Coverage | 14 | 2024 | 1939 | 2.350 |
Why?
|
Early Detection of Cancer | 21 | 2024 | 3202 | 2.200 |
Why?
|
Patient Protection and Affordable Care Act | 11 | 2024 | 1200 | 2.050 |
Why?
|
Relaxation Therapy | 6 | 2018 | 179 | 1.980 |
Why?
|
Insurance, Health | 16 | 2024 | 2501 | 1.980 |
Why?
|
Counseling | 20 | 2022 | 1548 | 1.950 |
Why?
|
Adaptation, Psychological | 25 | 2024 | 2628 | 1.810 |
Why?
|
Attitude to Health | 16 | 2020 | 2029 | 1.610 |
Why?
|
Quality of Life | 51 | 2024 | 13308 | 1.410 |
Why?
|
Fear | 6 | 2024 | 1462 | 1.360 |
Why?
|
Depression | 28 | 2023 | 8044 | 1.330 |
Why?
|
Pilot Projects | 32 | 2024 | 8555 | 1.300 |
Why?
|
Tobacco Use Disorder | 6 | 2019 | 700 | 1.250 |
Why?
|
Health Services Accessibility | 11 | 2019 | 5397 | 1.230 |
Why?
|
Neurofibromatosis 1 | 6 | 2015 | 560 | 1.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 17 | 2020 | 3986 | 1.150 |
Why?
|
Mind-Body Relations, Metaphysical | 3 | 2016 | 36 | 1.130 |
Why?
|
Telephone | 11 | 2020 | 624 | 1.130 |
Why?
|
Tobacco Use Cessation | 3 | 2022 | 93 | 1.110 |
Why?
|
Female | 222 | 2024 | 391270 | 1.080 |
Why?
|
Body Image | 4 | 2020 | 635 | 1.070 |
Why?
|
Social Stigma | 4 | 2021 | 734 | 1.050 |
Why?
|
Humans | 303 | 2024 | 760621 | 1.050 |
Why?
|
Acute Coronary Syndrome | 6 | 2021 | 2365 | 1.010 |
Why?
|
Cultural Diversity | 7 | 2010 | 365 | 1.000 |
Why?
|
Psychotherapy, Group | 3 | 2020 | 410 | 1.000 |
Why?
|
Palliative Care | 20 | 2022 | 3607 | 0.980 |
Why?
|
Mass Chest X-Ray | 3 | 2015 | 18 | 0.970 |
Why?
|
Middle Aged | 145 | 2024 | 220352 | 0.970 |
Why?
|
Attitude of Health Personnel | 14 | 2020 | 3865 | 0.960 |
Why?
|
Qualitative Research | 26 | 2023 | 2963 | 0.920 |
Why?
|
Male | 178 | 2024 | 359744 | 0.910 |
Why?
|
Health Communication | 2 | 2018 | 212 | 0.910 |
Why?
|
Siblings | 11 | 2024 | 824 | 0.910 |
Why?
|
Relaxation | 2 | 2014 | 51 | 0.890 |
Why?
|
Gastrointestinal Neoplasms | 11 | 2018 | 951 | 0.890 |
Why?
|
Telemedicine | 8 | 2022 | 3018 | 0.890 |
Why?
|
Self Efficacy | 5 | 2018 | 630 | 0.880 |
Why?
|
Neurofibromatosis 2 | 4 | 2014 | 385 | 0.870 |
Why?
|
Adult | 132 | 2024 | 219994 | 0.860 |
Why?
|
Psychological Tests | 2 | 2023 | 639 | 0.840 |
Why?
|
Parents | 5 | 2020 | 3549 | 0.840 |
Why?
|
Anxiety | 16 | 2022 | 4538 | 0.830 |
Why?
|
Motivation | 14 | 2020 | 1993 | 0.830 |
Why?
|
Physician-Patient Relations | 9 | 2016 | 3242 | 0.790 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6853 | 0.780 |
Why?
|
Program Development | 4 | 2020 | 1297 | 0.770 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9276 | 0.760 |
Why?
|
Interviews as Topic | 16 | 2020 | 2659 | 0.760 |
Why?
|
Social Support | 12 | 2020 | 2145 | 0.730 |
Why?
|
Temperance | 1 | 2020 | 87 | 0.720 |
Why?
|
Healthcare Disparities | 7 | 2023 | 3388 | 0.720 |
Why?
|
Breast Neoplasms | 18 | 2024 | 21025 | 0.710 |
Why?
|
Appointments and Schedules | 2 | 2024 | 442 | 0.710 |
Why?
|
Substance-Related Disorders | 5 | 2023 | 4371 | 0.680 |
Why?
|
Self Report | 5 | 2023 | 3711 | 0.670 |
Why?
|
Primary Health Care | 15 | 2021 | 4647 | 0.670 |
Why?
|
Focus Groups | 15 | 2018 | 1378 | 0.660 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 25942 | 0.660 |
Why?
|
Mass Screening | 11 | 2021 | 5423 | 0.650 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2023 | 1079 | 0.630 |
Why?
|
Perception | 6 | 2020 | 1195 | 0.620 |
Why?
|
Personnel, Hospital | 1 | 2020 | 285 | 0.620 |
Why?
|
Cancer Care Facilities | 4 | 2018 | 424 | 0.620 |
Why?
|
Neurofibromatoses | 4 | 2016 | 299 | 0.610 |
Why?
|
Aged | 85 | 2024 | 169152 | 0.610 |
Why?
|
Feasibility Studies | 17 | 2023 | 5201 | 0.610 |
Why?
|
Psychotherapy | 4 | 2023 | 1640 | 0.590 |
Why?
|
Employment | 5 | 2018 | 1112 | 0.580 |
Why?
|
Family Practice | 6 | 2016 | 510 | 0.580 |
Why?
|
Nursing Methodology Research | 1 | 2017 | 64 | 0.580 |
Why?
|
Infertility, Female | 2 | 2014 | 759 | 0.570 |
Why?
|
Advance Care Planning | 4 | 2021 | 697 | 0.570 |
Why?
|
Mammography | 7 | 2024 | 2427 | 0.560 |
Why?
|
Translating | 3 | 2016 | 148 | 0.560 |
Why?
|
Hospitals, General | 2 | 2020 | 795 | 0.550 |
Why?
|
Cost of Illness | 8 | 2024 | 1940 | 0.550 |
Why?
|
Self Care | 5 | 2022 | 793 | 0.540 |
Why?
|
Health Care Costs | 6 | 2017 | 3258 | 0.530 |
Why?
|
United States | 48 | 2024 | 72461 | 0.530 |
Why?
|
Emotions | 8 | 2023 | 2734 | 0.520 |
Why?
|
Medically Uninsured | 6 | 2024 | 843 | 0.520 |
Why?
|
Mental Health Services | 3 | 2018 | 1717 | 0.510 |
Why?
|
Patient Acceptance of Health Care | 9 | 2020 | 3164 | 0.510 |
Why?
|
Autistic Disorder | 3 | 2021 | 1216 | 0.510 |
Why?
|
Health Services Needs and Demand | 6 | 2020 | 1399 | 0.500 |
Why?
|
Postpartum Period | 5 | 2021 | 1167 | 0.500 |
Why?
|
Insurance, Disability | 1 | 2015 | 27 | 0.490 |
Why?
|
Exercise | 9 | 2020 | 5787 | 0.490 |
Why?
|
Models, Nursing | 1 | 2015 | 45 | 0.490 |
Why?
|
Endocarditis | 1 | 2019 | 351 | 0.480 |
Why?
|
Social Security | 1 | 2015 | 101 | 0.480 |
Why?
|
Disabled Persons | 3 | 2015 | 1223 | 0.480 |
Why?
|
Self Concept | 3 | 2013 | 1039 | 0.480 |
Why?
|
Caregivers | 9 | 2023 | 2224 | 0.470 |
Why?
|
Patient Compliance | 5 | 2024 | 2688 | 0.470 |
Why?
|
Neurilemmoma | 3 | 2014 | 523 | 0.470 |
Why?
|
Consensus | 1 | 2024 | 3113 | 0.470 |
Why?
|
Communication | 6 | 2021 | 3849 | 0.460 |
Why?
|
Loneliness | 2 | 2013 | 197 | 0.460 |
Why?
|
Sexual Behavior | 3 | 2018 | 2086 | 0.450 |
Why?
|
Uncertainty | 2 | 2022 | 754 | 0.450 |
Why?
|
Mental Disorders | 8 | 2023 | 6796 | 0.450 |
Why?
|
Sexual Dysfunction, Physiological | 3 | 2018 | 357 | 0.440 |
Why?
|
Health Personnel | 6 | 2019 | 3310 | 0.440 |
Why?
|
Internal Medicine | 6 | 2016 | 1048 | 0.440 |
Why?
|
Physicians, Family | 4 | 2009 | 349 | 0.440 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2015 | 167 | 0.440 |
Why?
|
Postnatal Care | 1 | 2015 | 260 | 0.430 |
Why?
|
Internship and Residency | 10 | 2010 | 5870 | 0.430 |
Why?
|
Social Perception | 2 | 2015 | 431 | 0.420 |
Why?
|
Research Design | 7 | 2017 | 6180 | 0.420 |
Why?
|
Cultural Competency | 3 | 2010 | 294 | 0.420 |
Why?
|
Young Adult | 33 | 2024 | 58741 | 0.420 |
Why?
|
Nicotinic Agonists | 3 | 2017 | 265 | 0.410 |
Why?
|
Community Health Services | 3 | 2012 | 654 | 0.410 |
Why?
|
Delivery of Health Care | 8 | 2020 | 5325 | 0.410 |
Why?
|
Communication Barriers | 4 | 2016 | 415 | 0.410 |
Why?
|
Socioeconomic Factors | 12 | 2024 | 7806 | 0.400 |
Why?
|
Follow-Up Studies | 19 | 2022 | 39261 | 0.400 |
Why?
|
Decision Making | 7 | 2018 | 3925 | 0.400 |
Why?
|
Headache | 2 | 2018 | 1249 | 0.400 |
Why?
|
Culture | 2 | 2015 | 622 | 0.390 |
Why?
|
Physician's Role | 3 | 2009 | 918 | 0.380 |
Why?
|
Medical Oncology | 7 | 2023 | 2313 | 0.380 |
Why?
|
Lymphoma | 1 | 2020 | 1898 | 0.380 |
Why?
|
Mothers | 5 | 2009 | 2186 | 0.370 |
Why?
|
Child | 30 | 2024 | 79806 | 0.360 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 926 | 0.350 |
Why?
|
Boston | 12 | 2019 | 9280 | 0.350 |
Why?
|
Patient Education as Topic | 5 | 2018 | 2315 | 0.340 |
Why?
|
Patient-Centered Care | 3 | 2019 | 1416 | 0.340 |
Why?
|
Practice Guidelines as Topic | 6 | 2024 | 7475 | 0.340 |
Why?
|
Mobility Limitation | 2 | 2010 | 402 | 0.340 |
Why?
|
Health Literacy | 3 | 2022 | 440 | 0.340 |
Why?
|
Pregnant Women | 2 | 2021 | 563 | 0.330 |
Why?
|
Health Benefit Plans, Employee | 1 | 2012 | 333 | 0.330 |
Why?
|
Comprehension | 1 | 2015 | 618 | 0.330 |
Why?
|
Guideline Adherence | 2 | 2018 | 2283 | 0.330 |
Why?
|
Race Relations | 2 | 2006 | 37 | 0.330 |
Why?
|
Quinoxalines | 1 | 2011 | 297 | 0.330 |
Why?
|
Lung | 6 | 2022 | 9994 | 0.330 |
Why?
|
Chronic Disease | 5 | 2020 | 9287 | 0.330 |
Why?
|
Benzazepines | 1 | 2011 | 311 | 0.320 |
Why?
|
Burnout, Professional | 2 | 2015 | 702 | 0.320 |
Why?
|
Adolescent | 32 | 2024 | 87810 | 0.320 |
Why?
|
Massachusetts | 14 | 2019 | 8803 | 0.320 |
Why?
|
Health Care Surveys | 10 | 2018 | 2435 | 0.320 |
Why?
|
Health Promotion | 5 | 2018 | 2206 | 0.320 |
Why?
|
Opioid-Related Disorders | 3 | 2022 | 2138 | 0.320 |
Why?
|
Truth Disclosure | 1 | 2012 | 432 | 0.310 |
Why?
|
Cross-Cultural Comparison | 2 | 2009 | 633 | 0.310 |
Why?
|
Clinical Competence | 6 | 2009 | 4783 | 0.310 |
Why?
|
Terminal Care | 7 | 2020 | 1758 | 0.310 |
Why?
|
Mental Health | 8 | 2023 | 3213 | 0.310 |
Why?
|
Behavior Therapy | 3 | 2022 | 868 | 0.310 |
Why?
|
Sexual Partners | 1 | 2012 | 753 | 0.300 |
Why?
|
Grief | 2 | 2022 | 254 | 0.300 |
Why?
|
Nicotine | 4 | 2008 | 677 | 0.300 |
Why?
|
Income | 3 | 2019 | 1875 | 0.300 |
Why?
|
Physicians, Primary Care | 3 | 2020 | 624 | 0.300 |
Why?
|
Quality of Health Care | 5 | 2017 | 4360 | 0.290 |
Why?
|
Sexuality | 1 | 2009 | 170 | 0.280 |
Why?
|
HIV Seropositivity | 1 | 2012 | 955 | 0.280 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2020 | 12293 | 0.280 |
Why?
|
Documentation | 4 | 2022 | 893 | 0.280 |
Why?
|
Risk Assessment | 13 | 2019 | 24123 | 0.280 |
Why?
|
Patient Participation | 4 | 2020 | 1439 | 0.280 |
Why?
|
Hydrocortisone | 1 | 2014 | 1803 | 0.280 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.270 |
Why?
|
Continuity of Patient Care | 3 | 2019 | 1066 | 0.270 |
Why?
|
Aging | 2 | 2022 | 8651 | 0.260 |
Why?
|
Clinical Protocols | 1 | 2012 | 1440 | 0.260 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2290 | 0.260 |
Why?
|
Intention | 2 | 2019 | 345 | 0.260 |
Why?
|
Family | 5 | 2023 | 3189 | 0.260 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2022 | 10344 | 0.260 |
Why?
|
Program Evaluation | 8 | 2020 | 2493 | 0.250 |
Why?
|
Pediatrics | 9 | 2017 | 3586 | 0.250 |
Why?
|
Behavior, Addictive | 1 | 2011 | 462 | 0.250 |
Why?
|
Pain | 4 | 2022 | 5066 | 0.250 |
Why?
|
Community Health Centers | 3 | 2024 | 453 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3426 | 0.240 |
Why?
|
Clinical Trials as Topic | 5 | 2023 | 8056 | 0.240 |
Why?
|
Depressive Disorder | 4 | 2016 | 3726 | 0.240 |
Why?
|
Depression, Postpartum | 1 | 2009 | 345 | 0.230 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2009 | 622 | 0.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2024 | 5649 | 0.230 |
Why?
|
Hospice Care | 3 | 2020 | 692 | 0.230 |
Why?
|
Breast | 1 | 2013 | 1963 | 0.230 |
Why?
|
Internet | 2 | 2016 | 3078 | 0.220 |
Why?
|
Bupropion | 2 | 2020 | 304 | 0.220 |
Why?
|
Schizophrenia | 2 | 2019 | 6915 | 0.220 |
Why?
|
Cost-Benefit Analysis | 5 | 2022 | 5508 | 0.220 |
Why?
|
Patient Selection | 3 | 2023 | 4283 | 0.220 |
Why?
|
Prenatal Care | 3 | 2008 | 1129 | 0.210 |
Why?
|
Medication Adherence | 9 | 2024 | 2165 | 0.210 |
Why?
|
Professional Competence | 2 | 2008 | 431 | 0.210 |
Why?
|
Child, Preschool | 11 | 2020 | 42063 | 0.210 |
Why?
|
Tobacco Smoke Pollution | 3 | 2015 | 812 | 0.210 |
Why?
|
HIV Infections | 4 | 2022 | 17165 | 0.210 |
Why?
|
Schools | 1 | 2011 | 1480 | 0.210 |
Why?
|
Tobacco, Smokeless | 1 | 2023 | 133 | 0.210 |
Why?
|
Veterans | 3 | 2021 | 2642 | 0.200 |
Why?
|
Treatment Outcome | 17 | 2023 | 65017 | 0.200 |
Why?
|
Health Expenditures | 4 | 2024 | 2362 | 0.200 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2061 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20509 | 0.200 |
Why?
|
Skin Neoplasms | 4 | 2014 | 5799 | 0.200 |
Why?
|
Models, Psychological | 2 | 2003 | 827 | 0.190 |
Why?
|
Prospective Studies | 14 | 2024 | 54303 | 0.190 |
Why?
|
Patient Discharge | 6 | 2018 | 3476 | 0.190 |
Why?
|
Managed Care Programs | 1 | 2007 | 939 | 0.190 |
Why?
|
Cotinine | 2 | 2020 | 203 | 0.190 |
Why?
|
Eligibility Determination | 2 | 2019 | 421 | 0.180 |
Why?
|
Postal Service | 1 | 2020 | 95 | 0.180 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2018 | 936 | 0.180 |
Why?
|
Social Justice | 1 | 2005 | 479 | 0.180 |
Why?
|
Recurrence | 5 | 2015 | 8482 | 0.170 |
Why?
|
Genetic Counseling | 3 | 2012 | 624 | 0.170 |
Why?
|
Anxiety Disorders | 3 | 2021 | 2714 | 0.170 |
Why?
|
Aged, 80 and over | 17 | 2022 | 58995 | 0.170 |
Why?
|
Unemployment | 2 | 2012 | 209 | 0.170 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2024 | 3529 | 0.170 |
Why?
|
Electronic Health Records | 7 | 2022 | 4775 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14495 | 0.160 |
Why?
|
Sex Factors | 5 | 2019 | 10547 | 0.160 |
Why?
|
Surgical Procedures, Operative | 1 | 2010 | 1913 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2018 | 5251 | 0.160 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2020 | 138 | 0.160 |
Why?
|
Needs Assessment | 4 | 2020 | 1139 | 0.160 |
Why?
|
Outpatients | 3 | 2022 | 1607 | 0.160 |
Why?
|
Affect | 5 | 2018 | 1480 | 0.160 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2882 | 0.160 |
Why?
|
Meditation | 2 | 2020 | 251 | 0.160 |
Why?
|
Habits | 2 | 2020 | 146 | 0.150 |
Why?
|
Prisoners | 1 | 2021 | 310 | 0.150 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3448 | 0.150 |
Why?
|
Medicaid | 2 | 2024 | 2815 | 0.150 |
Why?
|
Directive Counseling | 2 | 2017 | 171 | 0.150 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3150 | 0.150 |
Why?
|
Interpersonal Relations | 2 | 2017 | 1428 | 0.150 |
Why?
|
Widowhood | 1 | 2017 | 51 | 0.150 |
Why?
|
Ambulatory Care | 3 | 2022 | 2781 | 0.140 |
Why?
|
Professional-Patient Relations | 4 | 2018 | 726 | 0.140 |
Why?
|
Disabled Children | 1 | 2020 | 251 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2023 | 696 | 0.140 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1722 | 0.140 |
Why?
|
Prescription Fees | 1 | 2018 | 151 | 0.140 |
Why?
|
Financing, Personal | 1 | 2019 | 309 | 0.140 |
Why?
|
Psychometrics | 4 | 2021 | 3051 | 0.140 |
Why?
|
Medicare | 3 | 2024 | 6786 | 0.130 |
Why?
|
Hospices | 1 | 2019 | 256 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2019 | 270 | 0.130 |
Why?
|
Confidentiality | 1 | 2020 | 609 | 0.130 |
Why?
|
Comorbidity | 5 | 2019 | 10551 | 0.130 |
Why?
|
Age of Onset | 2 | 2018 | 3301 | 0.130 |
Why?
|
Saliva | 1 | 2020 | 820 | 0.130 |
Why?
|
Logistic Models | 7 | 2017 | 13314 | 0.130 |
Why?
|
Health Services Research | 2 | 2013 | 1810 | 0.130 |
Why?
|
Language | 2 | 2016 | 1533 | 0.130 |
Why?
|
Risk | 3 | 2018 | 9631 | 0.130 |
Why?
|
Women | 2 | 2012 | 225 | 0.130 |
Why?
|
Internal-External Control | 2 | 2011 | 359 | 0.130 |
Why?
|
Moral Obligations | 1 | 2016 | 93 | 0.130 |
Why?
|
Deception | 1 | 2016 | 98 | 0.130 |
Why?
|
Parent-Child Relations | 2 | 2019 | 758 | 0.130 |
Why?
|
Phobic Disorders | 1 | 2018 | 437 | 0.130 |
Why?
|
Waiting Lists | 1 | 2020 | 763 | 0.130 |
Why?
|
Retrospective Studies | 9 | 2023 | 80372 | 0.130 |
Why?
|
Patient Care Team | 3 | 2015 | 2511 | 0.120 |
Why?
|
Affective Symptoms | 2 | 2022 | 416 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 639 | 0.120 |
Why?
|
Rhode Island | 4 | 2003 | 349 | 0.120 |
Why?
|
Rectal Neoplasms | 1 | 2024 | 1152 | 0.120 |
Why?
|
Data Collection | 6 | 2009 | 3315 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29658 | 0.120 |
Why?
|
Pregnancy Complications | 2 | 2021 | 2942 | 0.120 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2020 | 3701 | 0.120 |
Why?
|
Bereavement | 1 | 2019 | 307 | 0.120 |
Why?
|
Combined Modality Therapy | 5 | 2022 | 8552 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2017 | 6015 | 0.120 |
Why?
|
Patients | 2 | 2019 | 906 | 0.120 |
Why?
|
Buprenorphine | 1 | 2022 | 654 | 0.120 |
Why?
|
Cohort Studies | 9 | 2019 | 41335 | 0.120 |
Why?
|
Reminder Systems | 1 | 2017 | 387 | 0.110 |
Why?
|
Physicians | 2 | 2003 | 4591 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6315 | 0.110 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 718 | 0.110 |
Why?
|
Neoplasm Staging | 4 | 2024 | 11152 | 0.110 |
Why?
|
Age Factors | 5 | 2019 | 18416 | 0.110 |
Why?
|
Hospitalization | 5 | 2019 | 10790 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8986 | 0.110 |
Why?
|
Neoplasms, Second Primary | 2 | 2015 | 1056 | 0.110 |
Why?
|
Social Control, Informal | 1 | 2013 | 44 | 0.110 |
Why?
|
Environment Design | 1 | 2014 | 172 | 0.110 |
Why?
|
Genetic Testing | 5 | 2012 | 3531 | 0.110 |
Why?
|
Infant, Newborn | 4 | 2018 | 26181 | 0.110 |
Why?
|
Travel | 1 | 2019 | 785 | 0.110 |
Why?
|
Peer Group | 3 | 2022 | 674 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 934 | 0.100 |
Why?
|
Empirical Research | 1 | 2013 | 120 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1677 | 0.100 |
Why?
|
Risk Factors | 12 | 2020 | 74359 | 0.100 |
Why?
|
Pregnancy | 9 | 2021 | 29749 | 0.100 |
Why?
|
Cranial Irradiation | 1 | 2015 | 391 | 0.100 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2001 | 0.100 |
Why?
|
Allostasis | 1 | 2013 | 72 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2325 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 17790 | 0.100 |
Why?
|
Professional Role | 1 | 2014 | 310 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.100 |
Why?
|
Hypertension | 1 | 2012 | 8594 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1504 | 0.100 |
Why?
|
Awareness | 2 | 2015 | 646 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1296 | 0.090 |
Why?
|
Staff Development | 1 | 2013 | 229 | 0.090 |
Why?
|
Clinical Coding | 1 | 2013 | 181 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20080 | 0.090 |
Why?
|
Obstetrics | 3 | 2008 | 667 | 0.090 |
Why?
|
Infant | 4 | 2018 | 36060 | 0.090 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2417 | 0.090 |
Why?
|
Oncology Service, Hospital | 1 | 2011 | 58 | 0.090 |
Why?
|
Tomography, Spiral Computed | 1 | 2012 | 273 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2018 | 1535 | 0.090 |
Why?
|
Ethics, Medical | 1 | 2016 | 783 | 0.090 |
Why?
|
Alabama | 1 | 2011 | 104 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 498 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 387 | 0.090 |
Why?
|
Interior Design and Furnishings | 1 | 2010 | 34 | 0.090 |
Why?
|
Heart Failure | 3 | 2020 | 11847 | 0.090 |
Why?
|
Professional-Family Relations | 1 | 2015 | 495 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15840 | 0.090 |
Why?
|
Withholding Treatment | 1 | 2015 | 613 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1801 | 0.090 |
Why?
|
Maryland | 1 | 2011 | 275 | 0.090 |
Why?
|
Self Administration | 1 | 2012 | 390 | 0.090 |
Why?
|
Students | 1 | 2020 | 1730 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1118 | 0.090 |
Why?
|
Teaching | 1 | 2017 | 1169 | 0.090 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 344 | 0.090 |
Why?
|
Coronary Disease | 2 | 2015 | 5990 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2024 | 1529 | 0.090 |
Why?
|
Medication Errors | 1 | 2016 | 784 | 0.090 |
Why?
|
Self-Examination | 1 | 2009 | 71 | 0.080 |
Why?
|
Pandemics | 4 | 2023 | 8624 | 0.080 |
Why?
|
Time Factors | 9 | 2018 | 40165 | 0.080 |
Why?
|
Research | 1 | 2017 | 1974 | 0.080 |
Why?
|
Military Personnel | 1 | 2018 | 1244 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12159 | 0.080 |
Why?
|
Education, Professional | 1 | 2009 | 51 | 0.080 |
Why?
|
Advance Directive Adherence | 1 | 2008 | 19 | 0.080 |
Why?
|
Overweight | 3 | 2014 | 2421 | 0.080 |
Why?
|
Health Status | 3 | 2017 | 4081 | 0.080 |
Why?
|
Health Surveys | 2 | 2017 | 4063 | 0.080 |
Why?
|
Occupations | 1 | 2011 | 515 | 0.080 |
Why?
|
Referral and Consultation | 3 | 2012 | 3598 | 0.080 |
Why?
|
Personal Satisfaction | 1 | 2012 | 643 | 0.070 |
Why?
|
Yoga | 1 | 2011 | 281 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1841 | 0.070 |
Why?
|
Risk-Taking | 2 | 2004 | 998 | 0.070 |
Why?
|
Patient Preference | 1 | 2014 | 922 | 0.070 |
Why?
|
Attitude | 1 | 2012 | 777 | 0.070 |
Why?
|
Designer Drugs | 1 | 2007 | 21 | 0.070 |
Why?
|
Administration, Oral | 2 | 2015 | 4035 | 0.070 |
Why?
|
Checklist | 1 | 2014 | 827 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 599 | 0.070 |
Why?
|
Efficiency, Organizational | 1 | 2011 | 697 | 0.070 |
Why?
|
Organizational Policy | 1 | 2009 | 429 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.070 |
Why?
|
Education, Continuing | 1 | 2007 | 114 | 0.070 |
Why?
|
Odds Ratio | 5 | 2015 | 9716 | 0.070 |
Why?
|
Parenting | 1 | 2012 | 695 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2008 | 306 | 0.070 |
Why?
|
Sleep | 1 | 2021 | 4751 | 0.060 |
Why?
|
Child Behavior | 1 | 2011 | 847 | 0.060 |
Why?
|
Multilingualism | 1 | 2006 | 87 | 0.060 |
Why?
|
Self-Evaluation Programs | 1 | 2005 | 29 | 0.060 |
Why?
|
Women's Health | 1 | 2015 | 2056 | 0.060 |
Why?
|
Least-Squares Analysis | 1 | 2006 | 369 | 0.060 |
Why?
|
Diabetes, Gestational | 1 | 2015 | 1242 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2003 | 0.060 |
Why?
|
Incidence | 3 | 2019 | 21392 | 0.060 |
Why?
|
Academic Medical Centers | 3 | 2016 | 2754 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4744 | 0.060 |
Why?
|
Thoracic Surgery | 1 | 2011 | 725 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12808 | 0.060 |
Why?
|
Educational Status | 4 | 2017 | 2515 | 0.060 |
Why?
|
Poverty | 2 | 2015 | 2695 | 0.060 |
Why?
|
Child Welfare | 1 | 2008 | 516 | 0.060 |
Why?
|
Demography | 2 | 2006 | 1650 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 195 | 0.060 |
Why?
|
Insurance, Dental | 1 | 2024 | 55 | 0.060 |
Why?
|
Utah | 2 | 2014 | 131 | 0.060 |
Why?
|
Radiotherapy | 1 | 2010 | 1504 | 0.060 |
Why?
|
Stereotyping | 1 | 2005 | 239 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3616 | 0.050 |
Why?
|
Population Surveillance | 1 | 2013 | 2608 | 0.050 |
Why?
|
Pleasure | 1 | 2023 | 40 | 0.050 |
Why?
|
Health Care Reform | 1 | 2012 | 1245 | 0.050 |
Why?
|
Gynecology | 2 | 2007 | 528 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3763 | 0.050 |
Why?
|
Curriculum | 2 | 2017 | 3718 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 932 | 0.050 |
Why?
|
Inpatients | 1 | 2014 | 2581 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4555 | 0.050 |
Why?
|
Azathioprine | 1 | 2023 | 356 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13502 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1049 | 0.050 |
Why?
|
Sibling Relations | 1 | 2021 | 46 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 296 | 0.050 |
Why?
|
Spouses | 1 | 2023 | 279 | 0.050 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 759 | 0.050 |
Why?
|
Prevalence | 6 | 2020 | 15687 | 0.050 |
Why?
|
Efficiency | 1 | 2024 | 477 | 0.050 |
Why?
|
Nursing Homes | 1 | 2008 | 1082 | 0.040 |
Why?
|
Life Style | 3 | 2012 | 3896 | 0.040 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 288 | 0.040 |
Why?
|
Blood Pressure | 2 | 2014 | 8525 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 353 | 0.040 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1895 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2809 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2007 | 1378 | 0.040 |
Why?
|
Tape Recording | 1 | 2018 | 75 | 0.040 |
Why?
|
Sickness Impact Profile | 1 | 2020 | 298 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2005 | 1191 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2010 | 6828 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2005 | 1403 | 0.040 |
Why?
|
Linear Models | 3 | 2016 | 5877 | 0.040 |
Why?
|
Weight Gain | 1 | 2008 | 2347 | 0.040 |
Why?
|
Marital Status | 2 | 2010 | 433 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6659 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6957 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1993 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2019 | 369 | 0.040 |
Why?
|
Speech Recognition Software | 1 | 2017 | 74 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1039 | 0.030 |
Why?
|
Reward | 1 | 2023 | 963 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2002 | 533 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2363 | 0.030 |
Why?
|
Baltimore | 1 | 2016 | 230 | 0.030 |
Why?
|
Probability | 3 | 2008 | 2475 | 0.030 |
Why?
|
Alleles | 1 | 2007 | 6898 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4810 | 0.030 |
Why?
|
Government Programs | 1 | 2017 | 280 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22053 | 0.030 |
Why?
|
Minority Groups | 1 | 2023 | 1201 | 0.030 |
Why?
|
Universities | 1 | 2020 | 992 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2176 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11345 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2014 | 208 | 0.030 |
Why?
|
Videoconferencing | 1 | 2016 | 203 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11712 | 0.030 |
Why?
|
American Cancer Society | 1 | 2014 | 66 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 573 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2004 | 3185 | 0.030 |
Why?
|
Nursing Evaluation Research | 1 | 2013 | 26 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2010 | 2932 | 0.030 |
Why?
|
Pennsylvania | 1 | 2015 | 615 | 0.030 |
Why?
|
Community-Institutional Relations | 1 | 2015 | 208 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1739 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4902 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2003 | 1824 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1578 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 956 | 0.030 |
Why?
|
Risk Management | 1 | 2016 | 558 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2013 | 208 | 0.030 |
Why?
|
Dance Therapy | 1 | 2011 | 8 | 0.030 |
Why?
|
Aftercare | 1 | 2018 | 916 | 0.020 |
Why?
|
Social Work | 1 | 2013 | 158 | 0.020 |
Why?
|
Automation | 1 | 2014 | 580 | 0.020 |
Why?
|
Social Marketing | 1 | 2011 | 52 | 0.020 |
Why?
|
Menopause | 1 | 2020 | 1640 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1257 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2017 | 908 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1500 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2013 | 389 | 0.020 |
Why?
|
Electronic Mail | 1 | 2013 | 213 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2698 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2013 | 349 | 0.020 |
Why?
|
Melanoma | 1 | 2009 | 5697 | 0.020 |
Why?
|
Oocytes | 1 | 1986 | 1165 | 0.020 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.020 |
Why?
|
Cytoskeleton | 1 | 1986 | 1167 | 0.020 |
Why?
|
Quality Improvement | 2 | 2019 | 3836 | 0.020 |
Why?
|
Disclosure | 1 | 2016 | 738 | 0.020 |
Why?
|
Social Conditions | 1 | 2011 | 119 | 0.020 |
Why?
|
Music Therapy | 1 | 2011 | 110 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 496 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2013 | 579 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2012 | 335 | 0.020 |
Why?
|
United States Health Resources and Services Administration | 1 | 2008 | 14 | 0.020 |
Why?
|
Personality | 1 | 2012 | 552 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3528 | 0.020 |
Why?
|
Executive Function | 1 | 2017 | 1374 | 0.020 |
Why?
|
Feedback | 1 | 2012 | 791 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1530 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 7818 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2011 | 810 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2015 | 1548 | 0.020 |
Why?
|
Training Support | 1 | 2008 | 108 | 0.020 |
Why?
|
Sample Size | 1 | 2011 | 840 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6360 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3301 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1166 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.020 |
Why?
|
Cost Savings | 1 | 2012 | 920 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10182 | 0.020 |
Why?
|
Health Priorities | 1 | 2009 | 374 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13630 | 0.020 |
Why?
|
Social Values | 1 | 2006 | 225 | 0.020 |
Why?
|
Operations Research | 1 | 2005 | 22 | 0.020 |
Why?
|
Long-Term Care | 1 | 2009 | 632 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2015 | 2629 | 0.020 |
Why?
|
Software Validation | 1 | 2005 | 59 | 0.020 |
Why?
|
Financing, Government | 1 | 2008 | 472 | 0.020 |
Why?
|
Spouse Abuse | 1 | 2006 | 179 | 0.020 |
Why?
|
Software Design | 1 | 2005 | 171 | 0.010 |
Why?
|
Parity | 1 | 2008 | 925 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1244 | 0.010 |
Why?
|
Dietary Fats | 2 | 2002 | 1992 | 0.010 |
Why?
|
Self-Help Groups | 1 | 2005 | 189 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1479 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4491 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6965 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3061 | 0.010 |
Why?
|
Preventive Health Services | 1 | 2008 | 570 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6479 | 0.010 |
Why?
|
Rural Population | 1 | 2014 | 2268 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2013 | 2062 | 0.010 |
Why?
|
Neutropenia | 1 | 2008 | 884 | 0.010 |
Why?
|
Attitude to Death | 1 | 2006 | 400 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2014 | 1830 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4417 | 0.010 |
Why?
|
Hospital Information Systems | 1 | 2005 | 394 | 0.010 |
Why?
|
Breast Self-Examination | 1 | 2002 | 33 | 0.010 |
Why?
|
Prejudice | 1 | 2006 | 563 | 0.010 |
Why?
|
Causality | 1 | 2008 | 1242 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2015 | 5425 | 0.010 |
Why?
|
Primary Prevention | 1 | 2008 | 1207 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4899 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2295 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1044 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2893 | 0.010 |
Why?
|
Delphi Technique | 1 | 2003 | 829 | 0.010 |
Why?
|
Leadership | 1 | 2009 | 1371 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1116 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8035 | 0.010 |
Why?
|
New York City | 1 | 2002 | 724 | 0.010 |
Why?
|
Vaginal Smears | 1 | 2002 | 495 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2002 | 760 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4925 | 0.010 |
Why?
|
Diet Surveys | 1 | 2002 | 1161 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12914 | 0.010 |
Why?
|
Ambystoma | 1 | 1986 | 5 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10827 | 0.010 |
Why?
|
Vitamins | 1 | 2004 | 1634 | 0.010 |
Why?
|
Immune Sera | 1 | 1986 | 613 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3465 | 0.010 |
Why?
|
Fertilization | 1 | 1986 | 197 | 0.010 |
Why?
|
Motor Activity | 1 | 2004 | 2687 | 0.010 |
Why?
|
Urban Population | 1 | 2002 | 2022 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14660 | 0.010 |
Why?
|
Obesity | 2 | 2008 | 12922 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15789 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 1986 | 1343 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15289 | 0.010 |
Why?
|
Animals | 1 | 1986 | 167963 | 0.000 |
Why?
|